Exel Composites Plc financial statements release Q1–Q4 2025: Order intake nearly tripled in Q4 and operating profit more than doubled in 2025 as Exel prepares to enter growth phase

Exel Composites reported a strong Q4 2025 with order intake up 173.2% to EUR 78.7m (EUR 168.6m for FY, +60.8%) and an order backlog of EUR 98.7m (+188.8% YoY). Revenue rose to EUR 29.0m in Q4 (+15.7%) and EUR 103.2m for the year (+3.6%), while operating profit turned positive to EUR 0.9m in Q4 and EUR 2.2m for FY (adjusted operating profit EUR 3.6m, more than doubled). Management highlighted multi‑year frame agreements (minimum EUR 47m for 2026–2029), a UK factory sale that contributed a one-off EUR 1.6m benefit, continued ramp-up in India, and expects revenue and adjusted operating profit to increase significantly in 2026; the board proposes no dividend for 2025.

Analysis

Market structure: Exel’s Q4 order intake (EUR 78.7m) and year-end backlog (EUR 98.7m) materially re-shape supply-demand in niche pultruded composite profiles for Energy, Transportation and Buildings — winners are suppliers of grid and lightweight structural components and tier-1 customers securing multi-year supply; losers are commodity metal suppliers for the same use-cases. The two multi-year frame agreements (EUR 47m min. 2026–29) shift near-term pricing power to Exel by improving capacity visibility and reducing spot-price exposure, supporting mid-single-digit to double-digit top-line growth if conversion rates hold.

Risk assessment: Key tail risks are large customer cancellations (project deferrals) and operational misses in India or Belgium transition that could reverse the order-to-revenue conversion (watch conversion rate <30% in H1 2026 as a red flag). Financial risks include rising leverage (net debt/adj. EBITDA 2.6x, net gearing ~80%) and reliance on one-off property gains (EUR 1.6m) that inflate 2025 operating profit; covenant stress or refinancing shocks would be high-impact.

Trade implications: Direct play is a tactical long in Exel (Nasdaq Helsinki: EXEL) to capture backlog conversion into 2026 revenue, sized to firm risk limits and paired with protective downside hedges; if options are available, use 9–12 month call spreads to express upside or buy equity with 3-month puts 25% OTM. Cross-asset: modest credit spread tightening for small-cap specialty industrials if execution continues; no immediate FX/commodity hedges required but monitor fiber/resin input prices.

Contrarian angles: Consensus may underappreciate convertibility of backlog and frame-agreement stickiness — if Exel sustains 2026 revenue growth >25% and margin expansion to ~5–7%, equity upside is underpriced (avg. share price ~EUR 0.37). Conversely, growth is front-loaded and operational execution is binary; mispricing could be large in either direction, so size positions small (1–3% portfolio) and escalate only after visible H1 call-off schedules and monthly production ramps.

Key Decisions for Investors

• Establish a 2–3% long position in Exel Composites (Nasdaq Helsinki: EXEL) within 1–4 weeks to capture 2026 backlog conversion; set a 12-month target of +35–50% and a hard stop-loss at -30% from entry or if reported H1 2026 backlog conversion <30%.
• If liquid options exist, buy 9–12 month call spreads (buy 100% OTM, sell 150% OTM) sized to 0.5–1% of portfolio to leverage upside; if options illiquid, pair equity long with 3-month protective puts 25% OTM sized 50–75% of equity notional to limit downside during execution ramp.
• Implement a pair trade: long EXEL (2% portfolio) vs short Hexcel (HXL) (1–1.5% notional) to play idiosyncratic outperformance of small-cap specialty composites; unwind if EXEL underperforms HXL by >15% over 90 days or if EXEL misses two consecutive monthly call-off targets.
• Cap exposure and monitor triggers: reduce/exit if net debt/adjusted EBITDA >3.5x, equity ratio falls below 25%, or recurring margins do not expand toward 5–7% by Q3 2026; re-up only after confirmed multi-month utilization >80% across factories and visible customer call-off schedules.